Diarrhea on Wegovy (semaglutide 2.4 mg): Incidence, Severity, and Realistic Expectations
How common diarrhea actually is on Wegovy, who gets it, how severe it tends to be, and what the STEP trial data shows about resolution timelines.
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 15 of 15 clinical reviews.
How common diarrhea actually is on Wegovy, who gets it, how severe it tends to be, and what the STEP trial data shows about resolution timelines.
A clinically detailed, week-by-week breakdown of diarrhea during Wegovy therapy, covering onset, peak, resolution, and the STEP trial data behind each phase, plus actionable management steps.
Evidence-based dietary, hydration, meal-timing, and supplement strategies to reduce diarrhea caused by Wegovy (semaglutide 2.4 mg), with specific foods to favor or avoid.
A clinician-tested protocol for assessing, treating, and escalating diarrhea caused by Wegovy (semaglutide 2.4 mg), with trial-backed timelines and clear decision points.
OTC and prescription options for treating diarrhea caused by Wegovy (semaglutide 2.4 mg), including loperamide dosing, prescription alternatives, drug interactions to avoid, and when to escalate care.
Evidence-based review of supplements that may reduce diarrhea caused by Wegovy (semaglutide 2.4 mg), including probiotics, psyllium, zinc, and glutamine, with dosing guidance and clinical trial data.
Clinical protocols for adjusting Wegovy dose titration to manage diarrhea, including slowed schedules, dose step-downs, pauses, and microdosing strategies with trial-backed evidence.
Evidence-based diet strategies to manage diarrhea caused by Wegovy (semaglutide 2.4 mg), including foods to eat, foods to avoid, and when to call your doctor.
Learn when diarrhea from Wegovy (semaglutide 2.4 mg) requires medical attention, why it happens, how long it lasts, and evidence-based strategies to manage this common GLP-1 side effect.
A clinical grading rubric for diarrhea caused by Wegovy (semaglutide 2.4 mg), including CTCAE grades, management strategies, and when to contact your prescriber.
Persistent diarrhea on Wegovy (semaglutide 2.4 mg) explained: why it happens, what the trial data show, how to manage it, and when to call your prescriber.
Explore why Wegovy (semaglutide 2.4 mg) causes diarrhea, how to manage it, and which GLP-1 and non-GLP-1 weight-loss alternatives carry a lower risk of this gastrointestinal side effect.
Clinical criteria for discontinuing Wegovy due to persistent diarrhea, including severity thresholds, lab markers, quality-of-life benchmarks, and evidence-based alternative therapies.
A clinician-reviewed explanation of the GLP-1 receptor mechanisms, gut motility changes, bile acid shifts, and microbiome alterations that cause diarrhea during Wegovy (semaglutide 2.4 mg) treatment.
A clinical-grade breakdown of how semaglutide 2.4 mg alters gut motility, delays gastric emptying, shifts bile acid metabolism, and disrupts the gut microbiome to produce diarrhea, plus what you can do about it.